Profile of portal hypertension in hepatosplenic schistosomiasis.

A. M. el-Hawey, S. A. Abou-Taleb, H. A. el-Gammal, M. M. Abdel-Rahman, A. A. Sabry

Research output: Contribution to journalArticle

Abstract

Intrasplenic pressure changes versus ova count in stool of schistosomal portal hypertension in cases of bilharzial hepatic fibrosis were studied before and after 40 mg/kg body weight praziquantel therapy. Praziquantel acts on the vascular level in which it decreases the portal hypertension caused by bilharziasis as detected by decreased size of portal and splenic veins diameter as well as a significant decrease of portal pressure by the decrease of intrasplenic pressure (P less than 0.05). On the other hand, praziquantel decrease bilharzial stool egg count after 3 months of therapy (P less than 0.05).

Original languageEnglish
Pages (from-to)305-309
Number of pages5
JournalJournal of the Egyptian Society of Parasitology
Volume22
Issue number2
Publication statusPublished - Aug 1 1992
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Profile of portal hypertension in hepatosplenic schistosomiasis.'. Together they form a unique fingerprint.

  • Cite this

    el-Hawey, A. M., Abou-Taleb, S. A., el-Gammal, H. A., Abdel-Rahman, M. M., & Sabry, A. A. (1992). Profile of portal hypertension in hepatosplenic schistosomiasis. Journal of the Egyptian Society of Parasitology, 22(2), 305-309.